Exact compound and country check

Tesamorelin in Malaysia

Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia.

Evidence lane
US research-market identity
Destination
Malaysia
Source records
3
Reviewed
21 July 2026
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

What does a search for Tesamorelin in Malaysia need to establish?

Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

02

Which official records should be checked for Tesamorelin in Malaysia?

Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search QUEST3+ Product Search from National Pharmaceutical Regulatory Agency for the destination product record and Product registration FAQ from National Pharmaceutical Regulatory Agency for the seller, establishment, or supply route in Malaysia. A match in one record does not replace the other two checks.

03

Does an online listing prove Tesamorelin is authorized or available in Malaysia?

No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Malaysia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Continue the exact comparison

Related country and compound records.

Compare another tracked name in Malaysia, or keep Tesamorelin fixed and change the destination within Asia-Pacific. The identity, product, and seller checks remain separate.

Continue the exact comparison

Tesamorelin in Asia-Pacific

Tesamorelin across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

Primary identity source: Check the FDA Purple Book product record / U.S. Food and Drug Administration
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Check the FDA Purple Book product record

Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Check the FDA Purple Book product record

QUEST3+ Product Search

QUEST3+ Product Search is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open QUEST3+ Product Search

Product registration FAQ

Product registration FAQ is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Product registration FAQ
Malaysia / Country guide

Malaysia market context.

Malaysia's NPRA distinguishes registered products from manufacturer, importer, and wholesaler licences. A MAL-looking number, hologram image, marketplace badge, research statement, or laboratory document should be matched to the current official product record and responsible entity.

  • NPRA defines a registered drug as one approved by the Drug Control Authority for sale or use in Malaysia and assigns it a registration number beginning with MAL.
  • NPRA says a product is considered registered when it appears in QUEST3+ with an active status, which can change with regulatory updates.
  • Manufacturers, importers, and wholesalers require separate licences for the relevant activities involving registered products, so a product result alone does not verify the seller route.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Search QUEST3+ by exact details

Use the NPRA product search with the MAL number, product name, holder, manufacturer, importer, or active ingredient, and confirm that the returned status is active at the time of the search.

02

Match the label and holder

Compare the registration number, product category, holder, manufacturer, dosage form, and pack to the offer. A copied MAL number or similar product name is not a complete match.

03

Separate supplier licensing

Confirm the relevant manufacturer, import, or wholesale authority independently because NPRA treats product registration and the licences for supply activities as different controls.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

Audit and handoff

Keep the exact record attached.